Bottom line
What is DILAX's expense ratio?
DILAX's expense ratio is 1.05%, or about $105 a year on every $10,000 invested. That is more expensive than 64% of international stock funds we track (median 0.9%). This share class also charges a front-end sales load of up to 4.75%, taken from your investment when you buy. Its expense ratio includes a 0.18% 12b-1 marketing fee.
Updated Feb 26, 2026
DILAX fee table
| Net expense ratio | 1.05% |
|---|---|
| Gross expense ratio | 1.05% |
| Management fee | 0.55% |
| 12b-1 (distribution) fee | 0.18% |
| Other expenses | 0.32% |
| Fee waiver / reimbursement | 0% |
| Max front-end sales load | 4.75% |
| Max deferred sales charge | 0.5% |
| Redemption fee | 0% |
Source: Fund prospectus fee table, filed Feb 26, 2026
What DILAX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| DILAX | $577 | $793 | $1,027 | $1,697 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.05% expense ratio costs roughly $57,900 in lost growth, versus about $50,300 for the median international stock fund (0.9%).